{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:58:43Z","timestamp":1780955923013,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ghir.2026.101699","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T01:17:12Z","timestamp":1775438232000},"page":"101699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Growth hormone treatment for small for gestational age children"],"prefix":"10.1016","volume":"84","author":[{"given":"Vivian","family":"Gallardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Teran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Cassorla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ghir.2026.101699_bb0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1210\/endrev\/bnad002","article-title":"International consensus guideline on small for gestational age: etiology and management from infancy to early adulthood","volume":"44","author":"Hokken-Koelega","year":"2023","journal-title":"Endocr. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ghir.2026.101699_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000191279","article-title":"The timing of early postnatal catch-up growth in normal, full-term infants born short for gestational age","volume":"48","author":"Karlberg","year":"1997","journal-title":"Horm. Res."},{"issue":"3","key":"10.1016\/j.ghir.2026.101699_bb0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.beem.2008.03.002","article-title":"Growth patterns in the growth-retarded premature infant","volume":"22","author":"Pilling","year":"2008","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"Suppl. 2","key":"10.1016\/j.ghir.2026.101699_bb0020","first-page":"7","article-title":"Children born small-for-gestational age: postnatal growth and hormonal status","volume":"49","author":"Albertsson-Wikland","year":"1998","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2026.101699_bb0025","author":"Pharmacia & Upjohn Company"},{"key":"10.1016\/j.ghir.2026.101699_bb0030","author":"European Medicines Agency"},{"key":"10.1016\/j.ghir.2026.101699_bb0035","first-page":"641","article-title":"Guideline for GH treatment in SGA short children","volume":"111","author":"The Japanese Society for Pediatric Endocrinology, Japan Society for Premature and Newborn Medicine","year":"2007","journal-title":"Nippon Shonika Gakkai Zasshi"},{"key":"10.1016\/j.ghir.2026.101699_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2431-11-66","article-title":"Latin American consensus: children born small for gestational age","volume":"11","author":"Boguszewski","year":"2011","journal-title":"BMC Pediatr."},{"issue":"3","key":"10.1016\/j.ghir.2026.101699_bb0045","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","article-title":"Management of the child born small for gestational age through to adulthood: a consensus statement of the international societies of pediatric endocrinology and the growth hormone research society","volume":"92","author":"Clayton","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.ghir.2026.101699_bb0050","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/er.2018-00083","article-title":"Children born small for gestational age: differential diagnosis, molecular genetic evaluation, and implications","volume":"39","author":"Finken","year":"2018","journal-title":"Endocr. Rev."},{"issue":"23","key":"10.1016\/j.ghir.2026.101699_bb0055","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1113\/JP274999","article-title":"Postnatal effects of intrauterine treatment of the growth-restricted ovine fetus with intra-amniotic insulin-like growth factor-1","volume":"596","author":"Spiroski","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.ghir.2026.101699_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ghir.2018.12.004","article-title":"Growth hormone therapy in children; research and practice - a review","volume":"44","author":"Collett-Solberg","year":"2019","journal-title":"Growth Hormon. IGF Res."},{"issue":"5","key":"10.1016\/j.ghir.2026.101699_bb0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1651-2227.1998.tb01495.x","article-title":"Three-year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation","volume":"87","author":"Fjellestad-Paulsen","year":"1998","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ghir.2026.101699_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1651-2227.1996.tb14289.x","article-title":"Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies","volume":"417","author":"de Zegher","year":"1996","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ghir.2026.101699_bb0075","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2007-0078","article-title":"Improvement in growth after two years of growth hormone therapy in very young children born small for gestational age and without spontaneous catch-up growth: results of a multicenter, controlled, randomized, open clinical trial","volume":"92","author":"Argente","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0080","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1210\/clinem\/dgac694","article-title":"Early growth hormone initiation leads to favorable long-term growth outcomes in children born small for gestational age","volume":"108","author":"Juul","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.ghir.2026.101699_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1203\/01.PDR.0000148716.71231.81","article-title":"Swedish study group for growth hormone treatment. Final height in short children born small for gestational age treated with growth hormone","volume":"57","author":"Dahlgren","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ghir.2026.101699_bb0090","first-page":"1887","article-title":"High-dose growth hormone treatment of short children born small for gestational age","volume":"81","author":"de Zegher","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0095","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1055\/a-2136-8654","article-title":"Long-term efficacy and safety of recombinant human growth hormone in children born small for gestational age","volume":"55","author":"Wu","year":"2023","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ghir.2026.101699_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1515\/JPEM.2008.21.5.423","article-title":"Efficacy and safety of growth hormone treatment in children born small for gestational age in Japan","volume":"21","author":"Tanaka","year":"2008","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/EJE-08-0301","article-title":"Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study","volume":"160","author":"Jung","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101699_bb0110","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1542\/peds.2004-1934","article-title":"Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term","volume":"115","author":"de Zegher","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2026.101699_bb0115","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1542\/peds.2009-0293","article-title":"Impact of growth hormone therapy on adult height of children born small for gestational age","volume":"124","author":"Maiorana","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2026.101699_bb0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1297\/cpe.29.159","article-title":"The long-term safety and effectiveness of growth hormone treatment in Japanese children with short stature born small for gestational age","volume":"29","author":"Horikawa","year":"2020","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101699_bb0125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1515\/jpem-2019-0438","article-title":"Growth and metabolic effects of long-term recombinant human growth hormone (rhGH) treatment in short children born small for gestational age: GH-RAST study","volume":"33","author":"Labarta","year":"2020","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1159\/000530572","article-title":"Growth hormone dose modulation and final height in short children born small for gestational age: French real-life data","volume":"96","author":"Coutant","year":"2023","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2026.101699_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11154-024-09911-y","article-title":"Effects of long-term treatment with recombinant growth hormone on growth outcome in children born small for gestational age: a systematic review","volume":"26","author":"Ferrigno","year":"2025","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ghir.2026.101699_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1112938","article-title":"Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a belgian study","volume":"14","author":"Becker","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2026.101699_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000354658","article-title":"Adult height and epigenotype in children with Silver-Russell syndrome treated with GH","volume":"80","author":"Binder","year":"2013","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2026.101699_bb0150","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/cen.14715","article-title":"Height and body mass index in molecularly confirmed Silver-Russell syndrome and the long-term effects of growth hormone treatment","volume":"97","author":"Lokulo-Sodipe","year":"2022","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101699_bb0155","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/jc.2015-4273","article-title":"Long-term results of GH treatment in Silver-Russell syndrome (SRS): do they benefit the same as non-SRS short-SGA?","volume":"101","author":"Smeets","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0160","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000295924","article-title":"Effect of long-term growth hormone treatment on final height of children with Russell-Silver syndrome","volume":"74","author":"Toumba","year":"2010","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2026.101699_bb0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000289570","article-title":"Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS","volume":"74","author":"Ranke","year":"2010","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2026.101699_bb0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jc.2007-1381","article-title":"Prediction model for adult height of small for gestational age children at the start of growth hormone treatment","volume":"93","author":"de Ridder","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.ghir.2026.101699_bb0175","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000516557","article-title":"Determinants of final height in patients born small for gestational age treated with recombinant growth hormone","volume":"94","author":"Adler","year":"2021","journal-title":"Horm. Res. Paediatr."},{"issue":"4","key":"10.1016\/j.ghir.2026.101699_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266329","article-title":"Long-term effectiveness of growth hormone therapy in children born small for gestational age: an analysis of LG growth study data","volume":"17","author":"Lee","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ghir.2026.101699_bb0185","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1210\/jc.2002-021172","article-title":"Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial","volume":"88","author":"Van Pareren","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1530\/EJE-14-0419","article-title":"A randomised controlled trial evaluating IGF1 titration in contrast to current GH dosing strategies in children born small for gestational age: the North European small-for-gestational-age study","volume":"171","author":"Jensen","year":"2014","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"10.1016\/j.ghir.2026.101699_bb0195","doi-asserted-by":"crossref","first-page":"E1149","DOI":"10.1152\/ajpendo.00410.2002","article-title":"A highly sensitive and specific assay for determination of IGF-I bioactivity in human serum","volume":"284","author":"Chen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0200","article-title":"Bioactive insulin-like growth factor (IGF)-I concentrations in children on growth hormone therapy","volume":"14","author":"Vilmann","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2026.101699_bb0205","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz118","article-title":"Increases in bioactive IGF do not parallel increases in total IGF-I during growth hormone treatment of children born SGA","volume":"105","author":"Wegmann","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4274\/jcrpe.v1i5.240","article-title":"Combined evaluation of IGF-1 and IGFBP-3 as an index of efficacy and safety in growth hormone treated patients","volume":"1","author":"S\u0131klar","year":"2009","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101699_bb0215","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000479691","article-title":"Circulating IGF-I, IGFBP-3 and the IGF-I\/IGFBP-3 molar ratio concentration and height outcome in prepubertal short children on rhGH treatment over two years of therapy","volume":"88","author":"Ballerini","year":"2017","journal-title":"Horm. Res. Paediatr."},{"issue":"1","key":"10.1016\/j.ghir.2026.101699_bb0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00399095","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome x): relation to reduced fetal growth","volume":"36","author":"Barker","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2026.101699_bb0225","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1297\/cpe.27.145","article-title":"Long-term safety and efficacy of daily recombinant human growth hormone treatment in Japanese short children born small for gestational age: final report from an open and multi-center study","volume":"27","author":"Tanaka","year":"2018","journal-title":"Clin. Pediatr. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101699_bb0230","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2265.2008.03195.x","article-title":"Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment","volume":"69","author":"de Kort","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2026.101699_bb0235","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1210\/jc.2012-1759","article-title":"Serum thyroid hormone levels in healthy children from birth to adulthood and in short children born small for gestational age","volume":"97","author":"Lem","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1651-2227.1997.tb18418.x","article-title":"Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years","volume":"423","author":"de Zegher","year":"1997","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ghir.2026.101699_bb0245","first-page":"3064","article-title":"Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial","volume":"84","author":"Sas","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0250","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2003.01905.x","article-title":"GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial","volume":"59","author":"Arends","year":"2003","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.ghir.2026.101699_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2265.2007.02913.x","article-title":"Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial","volume":"67","author":"Willemsen","year":"2007","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2026.101699_bb0260","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1210\/jc.2003-030962","article-title":"Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment","volume":"89","author":"Fjellestad-Paulsen","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0265","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1210\/clinem\/dgae616","article-title":"Somapacitan in children born SGA: 52-week efficacy, safety, and IGF-I response results from the phase 2 REAL5 study","volume":"110","author":"Juul","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2026.101699_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cen.15156","article-title":"A phase 2 study of PEGylated recombinant human growth hormone for 52 weeks in short children born small for gestational age in China","volume":"102","author":"Luo","year":"2025","journal-title":"Clin. Endocrinol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637426000213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:13:10Z","timestamp":1780953190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637426000213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"alternative-id":["S1096637426000213"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101699","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone treatment for small for gestational age children","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2026.101699","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101699"}}